Cargando…
Advances in the treatment of Hodgkin's lymphoma (Review)
Hodgkin's lymphoma (HL) is a unique B-cell lymphoproliferative malignancy that has a critical pathogenesis characterized by a sparse population of Hodgkin and Reed-Sternberg cells surrounded by numerous dysfunctional immune cells. Although systemic chemotherapy with or without radiotherapy, has...
Autores principales: | Che, Yuxuan, Ding, Xiaolei, Xu, Liye, Zhao, Jian, Zhang, Xian, Li, Na, Sun, Xiuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147096/ https://www.ncbi.nlm.nih.gov/pubmed/37026506 http://dx.doi.org/10.3892/ijo.2023.5509 |
Ejemplares similares
-
Secondary hemophagocytic lymphohistiocytosis triggered by peripheral T‐cell lymphoma: An unusual case report
por: Che, Yuxuan, et al.
Publicado: (2022) -
Recent advances in CAR T-cell therapy for lymphoma in China
por: Che, Yuxuan, et al.
Publicado: (2023) -
Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023) -
Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
por: Vellemans, Hélène, et al.
Publicado: (2021) -
Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)